Doctor Akihiro Tobe

Doctor Akihiro Tobe

University of Galway, Galway (Ireland)

Member of:

European Association of Percutaneous Cardiovascular Interventions

Mar 2012. Bachelor of Medicine, Nagoya University- Aichi, Japan. April 2012. Tosei General Hospital, Aichi, Japan. April 2019. Nagoya University Hospital, Department of Cardiology, Aichi, Japan. April 2023. CORRIB core lab, University of Galway, Galway, Ireland.

Presentations

Win ratio analysis of 1-year outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Event: EAPCI Summit 2026

Topic: Intervention

Session: Understanding the prognosis of TAVI procedures

Access

Conduction disturbance recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: substudy of the LANDMARK trial

Event: EAPCI Summit 2026

Topic: Intervention

Session: Understanding the prognosis of TAVI procedures

Access

Cardiac damage and 1-year clinical outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Event: EAPCI Summit 2026

Topic: Intervention

Session: Predicting outcomes after TAVI procedures

Access

Comprehensive assessment of 1-year echocardiograms after transcatheter aortic valve implantation: insights from the LANDMARK trial

Event: EAPCI Summit 2026

Topic: Intervention

Session: Valvular heart disease

Access

Changes of angiography-derived coronary microcirculatory resistance before and after drug-coated balloon treatment

Event: ESC Congress 2024

Topic: Coronary Microcirculation and Collaterals

Session: Detection of microvascular dysfunction (1)

Access

Heterogeneous carotid plaque is associated with cardiovascular events after percutaneous coronary intervention

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 6

Access

Albuminuria predicts worsening renal function at 1 month after transcatheter aortic valve implantation

Event: ESC Congress 2022

Topic: Aortic Valve Stenosis

Session: Predictors of outcomes in transcatheter aortic valve replacement

Access

Incidental findings on computed tomography for preoperative assessment before transcatheter aortic valve implantation in japanese patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Intervention

Session: Valvular heart disease and infective endocarditis e-posters

Access

Regression of electrocardiographic left ventricular hypertrophy after transcatheter aortic valve replacement for aortic stenosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Intervention

Session: Valvular heart disease and infective endocarditis e-posters

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Akihiro Tobe

Biography

Contributor content

Win ratio analysis of 1-year outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Conduction disturbance recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: substudy of the LANDMARK trial

Cardiac damage and 1-year clinical outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Comprehensive assessment of 1-year echocardiograms after transcatheter aortic valve implantation: insights from the LANDMARK trial

Changes of angiography-derived coronary microcirculatory resistance before and after drug-coated balloon treatment

Heterogeneous carotid plaque is associated with cardiovascular events after percutaneous coronary intervention

Albuminuria predicts worsening renal function at 1 month after transcatheter aortic valve implantation

Incidental findings on computed tomography for preoperative assessment before transcatheter aortic valve implantation in japanese patients

Regression of electrocardiographic left ventricular hypertrophy after transcatheter aortic valve replacement for aortic stenosis

ESC 365 is supported by

Doctor Akihiro Tobe Follow

Biography

Contributor content

Win ratio analysis of 1-year outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Conduction disturbance recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: substudy of the LANDMARK trial

Cardiac damage and 1-year clinical outcomes after transcatheter aortic valve implantation: substudy of the LANDMARK trial

Comprehensive assessment of 1-year echocardiograms after transcatheter aortic valve implantation: insights from the LANDMARK trial

Changes of angiography-derived coronary microcirculatory resistance before and after drug-coated balloon treatment

Heterogeneous carotid plaque is associated with cardiovascular events after percutaneous coronary intervention

Albuminuria predicts worsening renal function at 1 month after transcatheter aortic valve implantation

Incidental findings on computed tomography for preoperative assessment before transcatheter aortic valve implantation in japanese patients

Regression of electrocardiographic left ventricular hypertrophy after transcatheter aortic valve replacement for aortic stenosis

ESC 365 is supported by

Doctor Akihiro Tobe